Full-Time

Business Development Representative

Ketryx

Ketryx

51-200 employees

SaaS platform for regulated medical software

Compensation Overview

$60k - $70k/yr

+ Un-capped Commission + Equity Options

No H1B Sponsorship

Boston, MA, USA

Hybrid

Hybrid schedule; onsite work in Boston office.

Category
Sales & Account Management (1)
Required Skills
Sales

Get referred to Ketryx

See people who can refer or advise you

Requirements
  • Interest in building a career in sales.
  • Strong self-starter mentality capable of forging an independent path to get things done.
  • Ability to grasp extremely complex technical concepts quickly.
  • Strong written and verbal communication and interpersonal skills, with the ability to engage prospects effectively.
  • Ability to convey complex solutions in a clear and compelling manner.
  • A results-oriented mindset with a track record of meeting or exceeding targets.
  • Strong organizational skills and habits.
  • A proactive mindset, eager to learn and grow in a fast-paced sales environment.
  • Passion for healthcare technology and the ability to connect with leaders in the medical device industry.
Responsibilities
  • Generate qualified sales demos and meetings.
  • Proactively engage inbound and outbound leads through email, LinkedIn, and phone with tailored, personalized outreach.
  • Source opportunities with target accounts through cold emails and calls in collaboration with the marketing team and ABM campaigns.
  • Participation in online conversations (i.e. LinkedIn) with interested people, relevant conversation topics, and target accounts.
  • Conduct research on inbound and outbound target people and companies.
  • Collaborate with the sales team to advance target accounts.
  • Develop deep understanding of the product and target audiences.
  • Enter, update, and maintain CRM information on leads throughout the funnel.
Desired Qualifications
  • Previous experience in enterprise sales, medical device, or healthcare industry strongly preferred.

Ketryx offers a SaaS Connected Lifecycle Management platform for regulated medical software. It guides the full lifecycle from planning through verification and maintenance, ensuring compliance with FDA, IEC 62304, GMP, ISO 13485, and CFR 21 Part 11. The platform integrates traceability, documentation, Jira, and SBOM management to streamline development, quality, and compliance. It targets MedTech teams from startups to large enterprises, aiming to reduce compliance risk and development costs while speeding time to market.

Company Size

51-200

Company Stage

Series B

Total Funding

$57.1M

Headquarters

Cambridge, Massachusetts

Founded

2021

Get referred to Ketryx

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Ketryx says four of five top Fortune 500 MedTech firms use its platform.
  • The company closed a $39M Series B in February 2026, extending runway.
  • ISO 27001 certification became effective May 15, 2026, easing enterprise security reviews.

What critics are saying

  • Validated AI claims create audit exposure if customer incidents trigger FDA scrutiny.
  • Veeva, Atlassian, and Microsoft copy MCP-style integrations faster than Ketryx scales.
  • One FDA enforcement action freezes renewals and kills the startup.

What makes Ketryx unique

  • Ketryx sells validated AI agents inside regulated workflows, not generic compliance point tools.
  • Its March 31, 2026 MCP beta embeds compliance data directly into ChatGPT, Claude, and Copilot.
  • Bill Hawkins joined the board June 25, 2026, signaling deep MedTech credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Unlimited Paid Time Off

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

6%

2 year growth

8%
VentureFizz
Sep 30th, 2025
Hiring Unlocked: Ketryx Event Video - Company Details, Jobs, Culture, and More

Recently, Ketryx announced a $39M Series B round of funding led by Transformation Capital, with participation from existing investors including Lightspeed Venture Partners, MIT's E14 Fund, Ubiquity Ventures, and 53 Stations.

FinSMEs
Sep 4th, 2025
Ketryx Raises $39M in Series B Funding

Ketryx, a Cambridge, MA-based AI-powered compliance platform helping life sciences companies ship safer products faster, raised $39M in Series B funding

PR Newswire
Sep 4th, 2025
Ketryx Raises $39M Series B Round to Power the Future of Regulated Artificial Intelligence for Life Sciences

Ketryx raises $39M Series B round to power the future of regulated artificial intelligence for life sciences.

SiliconANGLE Media
Sep 4th, 2025
Ketryx raises $39M to help medical device makers ship safer products faster

Ketryx Corp., a company transforming product lifecycle development and compliance for medical device makers with artificial intelligence, today announced it has raised $39 million in a Series B funding round led by Transformation Capital.

TechIntelPro
May 2nd, 2025
Ketryx Launches First Validated AI Agents to Accelerate Safety-Critical Product Development

Ketryx launches first validated AI Agents to accelerate safety-critical product development.